These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 3283626

  • 1. [Induction and intensive combined therapy of acute myeloid leukemia in adults].
    Kurrle E, Ehninger G, Freund M, Heil G, Hoelzer D, Link H, Mitrou PS, Ohl S, Queisser W, Schlimok G.
    Onkologie; 1988 Feb; 11(1):5-9. PubMed ID: 3283626
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. High-dose cytosine arabinoside and daunorubicin postremission therapy in adults with de novo acute myeloid leukemia. Long-term follow-up of a prospective multicenter trial.
    Heil G, Mitrou PS, Hoelzer D, Freund M, Link H, Ehninger G, Steinke B, Ohl S, Wandt H, Fackler-Schwalbe E.
    Ann Hematol; 1995 Nov; 71(5):219-25. PubMed ID: 7492624
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.
    Hansen OP, Pedersen-Bjergaard J, Ellegaard J, Brincker H, Boesen AM, Christensen BE, Drivsholm A, Hippe E, Jans H, Jensen KB.
    Leukemia; 1991 Jun; 5(6):510-6. PubMed ID: 2056774
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group.
    Büchner T, Urbanitz D, Hiddemann W, Rühl H, Ludwig WD, Fischer J, Aul HC, Vaupel HA, Kuse R, Zeile G.
    J Clin Oncol; 1985 Dec; 3(12):1583-9. PubMed ID: 3906048
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long term follow-up of patients with acute myelogenous leukemia who received the daunorubicin, vincristine, and cytosine arabinoside regimen.
    Beguin Y, Sautois B, Forget P, Bury J, Fillet G.
    Cancer; 1997 Apr 01; 79(7):1351-4. PubMed ID: 9083157
    [Abstract] [Full Text] [Related]

  • 14. Remission induction and postremission therapy in acute myelogenous leukemia: British MRC Study.
    Rees JK, Gray RG.
    Haematol Blood Transfus; 1990 Apr 01; 33():243-8. PubMed ID: 1691131
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Postremission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment.
    Champlin R, Gajewski J, Nimer S, Vollset S, Landaw E, Winston D, Schiller G, Ho W.
    J Clin Oncol; 1990 Jul 01; 8(7):1199-206. PubMed ID: 1694236
    [Abstract] [Full Text] [Related]

  • 17. [A case of refractory acute myeloblastic leukemia who achieved partial remission by high dose cytosine arabinoside].
    Okamoto S, Ogata H, Yoshida T, Oheda Y, Murase T, Toyama K.
    Rinsho Ketsueki; 1984 May 01; 25(5):719-23. PubMed ID: 6590900
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results.
    Wolff SN, Herzig RH, Fay JW, Phillips GL, Lazarus HM, Flexner JM, Stein RS, Greer JP, Cooper B, Herzig GP.
    J Clin Oncol; 1989 Sep 01; 7(9):1260-7. PubMed ID: 2769327
    [Abstract] [Full Text] [Related]

  • 20. TAD-induction therapy for 175 adults with acute myeloid leukemia, followed by consolidation and maintenance therapy. The joint study of Ulm and Tübingen.
    Link H, Kurrle E, Frauer HM, Heil G, Heimpel H, Waller HD, Ostendorf P, Wilms K, Hoelzer D.
    Onkologie; 1986 Jun 01; 9(3):135-8. PubMed ID: 3528958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.